<unk>  (brand name Tymlos) is a parathyroid hormone-related protein (PTHrP) analog drug used to treat osteoporosis. Like the related drug teriparatide, it is an anabolic (i.e., bone growing) agent. In 2017, it was approved to treat postmenopausal osteoporosis in the United States.
Abaloparatide
Liranaftate
Insulin degludec
Ultralente insulin
Voglibose
Lente insulin
Regular insulin
Edotreotide